Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

The trial is jointly conducted at the Fudan University Shanghai Cancer Center and Peking University Cancer Hospital.

Scientist Stephen Krahling worked on a project at Merck called “Protocol 7” and was uniquely positioned to blow the whistle on what he learned.

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A vaccine to prevent breast cancer is showing good results, and moving into the next stage of clinical trials.

President Donald Trump’s pick to lead the National Institutes of Health answered sharp questions in a confirmation hearing ...

Researchers have developed a cancer vaccine method that can target virtually any solid tumor, amplifying the visibility of ...

The study followed 16 patients, including Barbara Brigham, who joined the trial after a routine scan discovered her ...

Two doses are all you need for the Shingrix vaccine, which is the vaccine given to people who have either had chickenpox or ...

Songwriter and music teacher Steve Young of Stevenage, Hertfordshire, made global news as one of the first people to be given ...